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Identiﬁcation and analysis of novel Spemann/Mangold organizer
genes
Heiko Lickert a, Doris Kinzel a, Ingo Burtscher a, Dietrich Truembach b,
Karsten Boldt c, Marius Uefﬁng c
a Institute of Stem Cell Research, Helmholtz Zentrum München,
Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
b Institute of Developmental Genetics, Helmholtz Zentrum München,
Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
c Institute of Human Genetics, Helmholtz Zentrum München,
Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
The Spemann/Mangold organizer regulates body axis formation;
however, the molecular nature of this regulation is still not fully
understood. We have combined genome-wide expression proﬁling of
Foxa2 mutants followed by mRNA expression screening to identify
novel genes speciﬁcally expressed in the mouse gastrula organizer:
the node. From 230 cDNAs, 6 novel node-speciﬁc genes were
identiﬁed, one of which appears during evolution speciﬁcally with
chordates. We have generated a null allele for this novel gene and
heterozygous embryos die due to outﬂow tract defects of the heart,
namely, the presence of a double outﬂow right ventricle, a situation
which often occurs in congenital heart disease. Moreover, hetero-
zygous mutants show post-axial polydactyly reminiscent of Pallister–
Hall syndrome in human, which can be caused through Gli3
mutations. Antibodies raised against the C terminus of the protein
reveal speciﬁc localization in vesicles, as well as cargo traveling along
the microtubules into the cilia of the node and ﬂagella of the sperm
tail. We also show co-localizationwith themicrotubule scaffold, motor
proteins, as well as with components of the Shh pathway. Recently it
was shown that intraﬂagellar transport proteins play a crucial role in
Shh signaling.We are currently testing a possible function of the novel
vertebrate-speciﬁc gene in modifying Shh signaling.
doi:10.1016/j.ydbio.2008.05.066
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Cell fate and pluripotency in the mouse embryo
Magdalena Zernicka-Goetz
Gurdon Institute, Cambridge, UK
The early mouse embryo provides a model system to explore
processes underlying the plasticity of the pluripotent state and how
cells leave it to enter different pathways. The ﬁrst differentiation
events in the embryo become apparent with the formation of the
trophectoderm, a differentiated tissue that envelopes a group of
pluripotent cell — the inner cell mass (ICM) by the blastocyst stage.
When and how do cells start to differ from each other in the embryo as0012-1606/$ – see front mattercell fate decisions are undertaken? Although blastomeres of the
preimplantation embryo are all pluripotent, as the embryo develops
some differences appear to develop between them such that they
would differ in their predisposition to embark upon differentiation
pathways. These differences are, at least in part, related to the
epigenetic information of each of these cells. We have identiﬁed
blastomeres in which the tendency to differentiate is more pro-
nounced and found that this correlates with low levels of speciﬁc
epigenetic modiﬁcation — methylation of histone H3 by the arginine
methyltransferase CARM1. Conversely higher levels of this modiﬁca-
tion have appeared to predispose blastomeres to contribute to the
pluripotent ICM cells. Indeed, when we overexpressed CARM1 in
individual blastomeres, their progeny was directed preferentially to
the ICM. The retention of pluripotency in such cells was associated
with the increased expression of Nanog. Consistent with these
ﬁndings in embryos, the down-regulation of CARM1 in ES cells results
in their differentiation. Its overexpression in ES cells leads to
methylation of arginine residues of histone H3 at the Nanog promoter,
an increased expression of Nanog and a signiﬁcant delay in the
response to differentiation signals. Thus both in the embryo and in ES
cells, CARM1 can similarly modulate the expression of this critical
gene to inﬂuence the likelihood of leaving or returning to the
pluripotent state. In other words, epigenetic asymmetries between
cells can act as drivers for lineage allocation.
doi:10.1016/j.ydbio.2008.05.067
Program/Abstract # 61
Histone deacetylase 1 (HDAC1) regulates histone acetylation,
development, and gene expression in preimplantation mouse
embryos
Pengpeng Ma, Richard M. Schultz
Department of Biology, University of Pennsylvania, Philadelphia, PA, USA
Superimposed on the activation of embryonic genome in mouse
early embryos is the formation of a chromatin-mediated transcrip-
tionally repressive state that arises in the late two-cell embryo and
becomes more pronounced with development. In this study, we
investigated expression and function of Class I histone deacetylases
(HDAC) HDAC1, HDAC2, and HDAC3 during preimplantation develop-
ment. HDAC1 is likely amajor deacetylase in preimplantation embryos
and its expression inversely correlates with changes in the acetylation
state of histone H4K5 during preimplantation development. RNAi-
mediated reduction of HDAC1 leads to hyperacetylation of histone H4
and a developmental delay even though expression of HDAC2 and
HDAC3 is signiﬁcantly induced in Hdac1-suppresssed embryos;
increased expression of p21Cip1/Waf may contribute to the observed
developmental delay. RNAi-mediated reduction of HDAC2 has no
486 ABSTRACTS / Developmental Biology 319 (2008) 485–486noticeable effect on preimplantation development, suggesting that
individual HDACs have distinct functions during preimplantation
development. Although RNAi-mediated targeting of Hdac3 mRNA
was very efﬁcient, maternal HDAC3 protein was stable during
preimplantation development, thereby preventing an examination of
its role. HDAC1 knockdown does not increase the rate of global
transcription in late 2-cell embryos, but does result in elevated levels of
expression of a subset of genes; this increased expression correlates
with hyperacetylation of histone H4. Results of these experiments
suggest that HDAC1 is involved in the development of a transcription-
ally repressive state that initiates in 2-cell embryos.
doi:10.1016/j.ydbio.2008.05.068
Program/Abstract # 62
Roles of Neurogenin and Geminin in vertebrate neurogenesis
Jong-Won Lim, Kristen L. Kroll
Washington University School of Medicine, Department of
Developmental Biology, St. Louis, MO, USA
Proneural basic helix–loop–helix transcription factors regulate cell
fate commitment and differentiation in neurogenesis. However, their
proneural functions are not well understood, in part due to a lack of
information about their target genes. Here, we identiﬁed direct
transcriptional targets of the bHLH transcription factor Neurogenin.
We found that Neurogenin regulates neurogenesis by activating
transcription factors, cell signaling components, and genes regulating
cytoskeleton rearrangement and cell migration. Some of these target
genes are induced by Neurogenin in both Xenopus and mouse, and
comprise conserved effectors mediating Neurogenin activity in
vertebrates. We computationally deﬁned consensus sequences for
Neurogenin binding and identiﬁed responsive enhancers regulated by
Neurogenin in seven target loci. These enhancers commonly contained
clustered, conserved consensus binding sites and drove neural tissue-
speciﬁc expression in transgenic Xenopus embryos. We used the
Neurogenin binding consensus and a computational approach to
predict additional target genes involved in neural development at a
genome-wide level. Previously, we also demonstrated that the novel
nuclear protein Geminin maintains neural progenitors and blocks
neuronal differentiation, at least in part by antagonizing Neurogenin's
ability to activate its target genes. To deﬁne how Geminin regulates
neurogenesis, we recently identiﬁed a subset of Neurogenin direct
targets that are repressed by Geminin. We are now using these target
genes to characterize how antagonism between Geminin and Neuro-
genin regulates transcriptional programs controlling neurogenesis.
doi:10.1016/j.ydbio.2008.05.069
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Distinctive chromatin of promoters for embryo development in
sperm
Brad R. Cairns a, Sue Hammoud a,b,c, David Nix a, Haiying Zhang a,
Jahnvi Purwar a, Douglas Carrell b,c
a HHMI and Huntsman Cancer Institute, University of Utah School of
Medicine, Salt Lake City, UT 84102, USA
b Department of Surgery, University of Utah School of Medicine, Salt Lake
City, UT 84102, USA
c Department of Obstetrics and Gynecology, University of Utah School of
Medicine, Salt Lake City, UT 84102, USAAs nucleosomes are widely replaced by protamine in human
sperm, the epigenetic contribution of the paternal genome to
development would appear quite limited (beyond the known
imprinted genes). However, our genome-wide approach ﬁnds the
retained nucleosomes enriched at the promoters of many transcrip-
tion factor families and signaling proteins that help guide embryo
development (termed developmental promoters). Although the bulk
sperm genome is hypermethylated relative to the egg, we ﬁnd that
developmental promoters are strikingly hypomethylated in sperm.
Furthermore, these developmental promoters selectively acquire DNA
methylation during differentiation, suggesting that development is
accompanied by the targeting of DNA methylation to particular
developmental promoters to silence their activity, possibly to restrict
alternative cell fate decisions. In ES cells, many developmental
promoters are occupied by PRC2 and also by pluripotency factors
(Oct4 or Nanog). We observe a striking overlap between the
promoters bound by these factors in ES cells, and the developmental
promoters in sperm that are hypomethylated and histone bound,
raising the possibility that one or more of these ES cell factors might
contribute to the chromatin state of developmental promoters in
sperm. Taken together, these results suggest the formation of
distinctive chromatin states at developmental promoters in sperm,
possibly to promote developmental totipotency.
doi:10.1016/j.ydbio.2008.05.070
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β-catenin-mediated histone arginine methylation poises
organizer genes for expression prior to the MBT
Shelby A. Blythe, Peter S. Klein
University of Pennsylvania, Philadelphia, PA, USA
The Wnt/β-catenin signaling pathway directs multiple cell fate
decisions during embryogenesis. In early Xenopus laevis embryos,
this pathway speciﬁes dorsal cell fates by activating genes that will
give rise to Spemann's organizer. Previously, we have shown that
Wnt/β-catenin functions during a discrete window of time prior to
the midblastula transition (MBT) to activate gene expression. We
have also reported β-catenin/TCF-dependent transcription before the
MBT despite large-scale transcriptional repression. This indicates that
β-catenin functions during pre-MBT development to regulate gene
expression and that this information is heritable through multiple
cell divisions. We hypothesize that β-catenin recruits chromatin
remodeling factors to promoters prior to the MBT to deposit heritable
marks of transcriptional activation. Promoters bearing these marks
would thus be poised to begin transcription. We ﬁnd that β-catenin
and RNA Pol II interact with organizer gene promoters before the
MBT and are both required during this time to deposit histone
modiﬁcations associated with transcriptional activation. To deter-
mine how these marks are established, we have characterized a β-
catenin-associated histone methyltransferase (HMT) activity. The
arginine HMT PRMT2 associates with β-catenin before the MBT and
is thereby recruited to target promoters. PRMT2′s activity at TCF sites
is sufﬁcient to induce secondary dorsal axes and rescue loss of β-
catenin. We conclude that β-catenin-mediated histone arginine
methylation is an initial step in the establishment of heritable, active
chromatin architecture at organizer target genes.
doi:10.1016/j.ydbio.2008.05.071
